Terms: = Germ cell tumor AND NR4A3, MINOR, 8013, ENSG00000119508, Q92570, CHN, NOR1, CSMF
2179 results:
1. White horses - non-coding sequences drive premature hair greying and predisposition to melanoma.
Andersson L
Ups J Med Sci; 2024; 129():. PubMed ID: 38571883
[TBL] [Abstract] [Full Text] [Related]
2. Ruptured Ovarian Cystic Teratoma: A Rare Diagnosis, Easily to Be Confused with Peritoneal Carcinomatosis.
Costachescu D; Motofelea AC; Malita D; Birsasteanu F; Ionita I; Motofelea N; Jura CA; Bacila IF; Bacila M; Motoi S
Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541186
[TBL] [Abstract] [Full Text] [Related]
3. The Impact of Posttreatment Imaging in Peptide Receptor Radionuclide Therapy.
Yadav S; Lawhn-Heath C; Paciorek A; Lindsay S; Mirro R; Bergsland EK; Hope TA
J Nucl Med; 2024 Mar; 65(3):409-415. PubMed ID: 38428966
[TBL] [Abstract] [Full Text] [Related]
4. Guidelines for outpatient administration of naxitamab: Experience from Atrium Health Levine Children's Hospital.
Trovillion EM; Michael M; Jordan CC; Brown L; Phillips K; Oesterheld J; Saulnier-Sholler G
Cancer Med; 2024 Feb; 13(3):e7045. PubMed ID: 38396377
[TBL] [Abstract] [Full Text] [Related]
5. The need for paradigm shift: prognostic significance and implications of standard therapy-related systemic immunosuppression in glioblastoma for immunotherapy and oncolytic virotherapy.
Stepanenko AA; Sosnovtseva AO; Valikhov MP; Chernysheva AA; Abramova OV; Naumenko VA; Chekhonin VP
Front Immunol; 2024; 15():1326757. PubMed ID: 38390330
[TBL] [Abstract] [Full Text] [Related]
6. Adoptive cell therapy for high grade gliomas using simultaneous temozolomide and intracranial mgmt-modified γδ t cells following standard post-resection chemotherapy and radiotherapy: current strategy and future directions.
Nabors LB; Lamb LS; Goswami T; Rochlin K; Youngblood SL
Front Immunol; 2024; 15():1299044. PubMed ID: 38384458
[TBL] [Abstract] [Full Text] [Related]
7. The ATM Ser49Cys Variant Effects ATM Function as a Regulator of Oncogene-Induced Senescence.
Atkinson C; McInerney-Leo AM; Proctor M; Lanagan C; Stevenson AJ; Dehkhoda F; Caole M; Maas E; Ainger S; Pritchard AL; Johansson PA; Leo P; Hayward NK; Sturm RA; Duncan EL; Gabrielli B
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338943
[TBL] [Abstract] [Full Text] [Related]
8. Recent-Onset Melanoma and the Implications of the Excessive Use of Tanning Devices-Case Report and Review of the Literature.
Nurla LA; Wafi G; Tatar R; Dorobanțu AM; Chivu M; Popa LG; Giurcăneanu C; Orzan OA
Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38276066
[No Abstract] [Full Text] [Related]
9. Complications following resection of primary and recurrent pediatric posterior fossa ependymoma.
Malhotra AK; Nobre L; Ibrahim GM; Kulkarni AV; Drake JM; Rutka JT; Taylor MD; Ramaswamy V; Dirks PB; Dewan MC
J Neurosurg Pediatr; 2024 Apr; 33(4):367-373. PubMed ID: 38241689
[TBL] [Abstract] [Full Text] [Related]
10. Ovarian non-gestational placental site trophoblastic tumor with lung metastasis: further evidence for a distinct category of trophoblastic neoplasm.
Shahi M; Katsakhyan L; Hopkins M; Allen-Rhoades W; Cepress MK; Langstraat C; Ishitani MB; Vang R; Ronnett BM; Xing D
Diagn Pathol; 2024 Jan; 19(1):3. PubMed ID: 38172961
[TBL] [Abstract] [Full Text] [Related]
11. VAMP7j: A Splice Variant of Human VAMP7 That Modulates Neurite Outgrowth by Regulating L1CAM Transport to the Plasma Membrane.
Gasparotto M; Dall'Ara E; Vacca M; Filippini F
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139155
[TBL] [Abstract] [Full Text] [Related]
12. The Use of rAAV2-RB1-Mediated Gene Therapy in Retinoblastoma.
Shi H; He X; Yang Z; Liao Q; Ruan J; Ge S; Chai P; Jia R; Fan J; Wen X; Fan X
Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):31. PubMed ID: 38133505
[TBL] [Abstract] [Full Text] [Related]
13. Liver metastases of neuroendocrine tumors: Conventional transarterial chemoembolization and thermal ablation.
Vogl TJ; Gruber-Rouh T; Naguib NNN; Lingwal N; Bolik P
Rofo; 2024 Apr; 196(4):381-389. PubMed ID: 38109897
[TBL] [Abstract] [Full Text] [Related]
14. The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.
Kilburn LB; Khuong-Quang DA; Hansford JR; Landi D; van der Lugt J; Leary SES; Driever PH; Bailey S; Perreault S; McCowage G; Waanders AJ; Ziegler DS; Witt O; Baxter PA; Kang HJ; Hassall TE; Han JW; Hargrave D; Franson AT; Yalon Oren M; Toledano H; Larouche V; Kline C; Abdelbaki MS; Jabado N; Gottardo NG; Gerber NU; Whipple NS; Segal D; Chi SN; Oren L; Tan EEK; Mueller S; Cornelio I; McLeod L; Zhao X; Walter A; Da Costa D; Manley P; Blackman SC; Packer RJ; Nysom K
Nat Med; 2024 Jan; 30(1):207-217. PubMed ID: 37978284
[TBL] [Abstract] [Full Text] [Related]
15. NRF1 Alleviated Oxidative Stress of Glioblastoma cells by Regulating nor1.
Wang J; Chen S; Xiang W; Zhu Q; Ren N
Folia Biol (Praha); 2023; 69(1):13-21. PubMed ID: 37962027
[TBL] [Abstract] [Full Text] [Related]
16. Glioblastoma/high-grade glioma with a primitive neuronal component including rhabdoid differentiation that was difficult to diagnose: A case report.
Kumagai M; Takata S; Watanabe T; Shioya A; Han J; Shimasaki M; Ueda Y; Hayashi Y; Yamada S
Pathol Res Pract; 2023 Nov; 251():154830. PubMed ID: 37890269
[TBL] [Abstract] [Full Text] [Related]
17. The diagnostic yield of preoperative screening for oral cancer in dogs over 15 years, part 1: locoregional screening.
Goldschmidt S; Soltero-Rivera M; Quiroz A; Wong K; Rebhun R; Zwingenberger A; Ren Y; Taylor S; Arzi B
J Am Vet Med Assoc; 2023 Dec; 261(S2):S14-S23. PubMed ID: 37863103
[TBL] [Abstract] [Full Text] [Related]
18. Assessment of Brain Tumour Perfusion Using Early-Phase
Filss CP; Cramer J; Löher S; Lohmann P; Stoffels G; Stegmayr C; Kocher M; Heinzel A; Galldiks N; Wittsack HJ; Sabel M; Neumaier B; Scheins J; Shah NJ; Meyer PT; Mottaghy FM; Langen KJ
Mol Imaging Biol; 2024 Feb; 26(1):36-44. PubMed ID: 37848641
[TBL] [Abstract] [Full Text] [Related]
19. Health care service use by people diagnosed with invasive melanoma in Queensland: a benefit incidence analysis.
Lindsay D; Whiteman DC; Olsen CM; Gordon LG
Med J Aust; 2023 Nov; 219(9):417-422. PubMed ID: 37807891
[TBL] [Abstract] [Full Text] [Related]
20. A phase I, single-center, open-label study to investigate the absorption, distribution, metabolism and excretion of encorafenib following a single oral dose of 100 mg [
Wollenberg L; Hahn E; Williams J; Litwiler K
Pharmacol Res Perspect; 2023 Oct; 11(5):e01140. PubMed ID: 37775918
[TBL] [Abstract] [Full Text] [Related]
[Next]
